FDA approves ReSure sealant for preventing fluid leaks after cataract surgery

The U.S. Food and Drug Administration approved the ReSure sealant (Ocular Therapeutix) for sale in the U.S., the company announced Jan. 9.The ReSure sealant is indicated for “the prevention of postoperative fluid egress from incisions with demonstrated wound leak following cataract surgery,” the company said in a press release. It is the first product of its kind to be approved by the FDA for ophthalmic use.“Receiving approval to commercialize this product is a huge milestone for the company,” Amar Sawhney, PhD, President and CEO of Ocular Therapeutix, said in a news release (Read more...)

Full Story →